KriSan Biotech is a global Contract Development and Manufacturing Organization (CDMO) since 2015. The team have 20+ years’ experience in pharmaceutical development and manufacturing. We offer flexible and scalable one-stop shop service for antibody-drug conjugate (ADC), small molecule, peptide, and oligonucleotide along with lipid nanoparticle (LNP) from pre-clinical to commercialization. As of August 31, 2023, we provided 93+ products to our worldwide partners.

  • Specialized in Medium-Scale & High-Barrier Drug Process Development and Production Services
  • Committed to Building and Integrating Differentiated Technology Platforms
  • Become a Leading Small Molecule and ADC drug CDMO in Asia